UY24937A1 - Forma hidratada de un derivado de 4-nitrobenzamida - Google Patents

Forma hidratada de un derivado de 4-nitrobenzamida

Info

Publication number
UY24937A1
UY24937A1 UY24937A UY24937A UY24937A1 UY 24937 A1 UY24937 A1 UY 24937A1 UY 24937 A UY24937 A UY 24937A UY 24937 A UY24937 A UY 24937A UY 24937 A1 UY24937 A1 UY 24937A1
Authority
UY
Uruguay
Prior art keywords
gives
product
nitrobenzamide
pharmaceutically acceptable
spectrum containing
Prior art date
Application number
UY24937A
Other languages
English (en)
Inventor
Paul Jeffrey Westlake
Graham Ralph Slater
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of UY24937A1 publication Critical patent/UY24937A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención se refiere a un nuevo producto farmacéutico, a un procedimiento para la preparación del producto farmacéutico y al uso del producto en medicina. El producto de la invención es el Hidrocloruro de N-(3-((2-(3,4-dimetoxifenil)etil)amino)propil)-4-nitrobenzamida hidratado, caracterizado porque: (i) contiene agua en la proporción de 1,7 a 2,4 equivalentes molares; y/o (ii) tiene un punto de fusión superior a 145s C; y/o (iii) da un espectro infrarrojo que contiene picos a 3510, 3342, 3076, 1665, 1598, 1343, 1330, 1216 y 801cm-1; y/o (iv) da un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamientos químicos; y/o (v) da un patrón de difracción en polvo de rayos x (XPRD). Este compuesto o sus sales farmacéuticamente aceptables y/o uno de sus solvatos farmacéuticamente aceptables se utilizan en el tratamiento o profilaxis de arritmias y los trastornos isquémicos del ritmo.
UY24937A 1997-03-27 1998-03-26 Forma hidratada de un derivado de 4-nitrobenzamida UY24937A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706376.2A GB9706376D0 (en) 1997-03-27 1997-03-27 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
UY24937A1 true UY24937A1 (es) 2000-12-29

Family

ID=10809958

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24937A UY24937A1 (es) 1997-03-27 1998-03-26 Forma hidratada de un derivado de 4-nitrobenzamida

Country Status (37)

Country Link
US (1) US20040092771A1 (es)
EP (1) EP0971882B1 (es)
JP (1) JP2001518088A (es)
KR (1) KR20010005566A (es)
CN (1) CN1257478A (es)
AP (1) AP1205A (es)
AT (1) ATE228997T1 (es)
AU (1) AU741476B2 (es)
BG (1) BG103829A (es)
BR (1) BR9809054A (es)
CA (1) CA2285197A1 (es)
DE (1) DE69809891T2 (es)
DK (1) DK0971882T3 (es)
DZ (1) DZ2452A1 (es)
EA (1) EA002439B1 (es)
EG (1) EG21226A (es)
ES (1) ES2189163T3 (es)
GB (1) GB9706376D0 (es)
HK (1) HK1025089A1 (es)
HU (1) HUP0001683A3 (es)
ID (1) ID22787A (es)
IL (1) IL132042A0 (es)
IN (1) IN188180B (es)
MA (1) MA26477A1 (es)
NO (1) NO994682D0 (es)
NZ (1) NZ337794A (es)
OA (1) OA11200A (es)
PE (1) PE61799A1 (es)
PL (1) PL335879A1 (es)
PT (1) PT971882E (es)
SK (1) SK283056B6 (es)
TR (1) TR199902356T2 (es)
TW (1) TW518318B (es)
UA (1) UA57066C2 (es)
UY (1) UY24937A1 (es)
WO (1) WO1998043947A1 (es)
ZA (1) ZA982558B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923933D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Lab Novel pharmaceutical
GB9923934D0 (en) * 1999-10-08 1999-12-08 Smithkline Beecham Plc Novel pharmaceutical
US8483008B2 (en) * 2008-11-08 2013-07-09 Westerngeco L.L.C. Coil shooting mode

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer

Also Published As

Publication number Publication date
JP2001518088A (ja) 2001-10-09
AP1205A (en) 2003-09-17
BR9809054A (pt) 2000-08-01
AP9901651A0 (en) 1999-09-30
TW518318B (en) 2003-01-21
ATE228997T1 (de) 2002-12-15
HK1025089A1 (en) 2000-11-03
DE69809891D1 (de) 2003-01-16
DZ2452A1 (fr) 2003-01-18
NO994682L (no) 1999-09-24
BG103829A (bg) 2000-04-28
IN188180B (es) 2002-08-31
ID22787A (id) 1999-12-09
EG21226A (en) 2001-03-31
ES2189163T3 (es) 2003-07-01
EP0971882A1 (en) 2000-01-19
HUP0001683A3 (en) 2002-11-28
NZ337794A (en) 2001-06-29
AU7334198A (en) 1998-10-22
IL132042A0 (en) 2001-03-19
PT971882E (pt) 2003-04-30
HUP0001683A2 (hu) 2000-09-28
GB9706376D0 (en) 1997-05-14
PL335879A1 (en) 2000-05-22
SK130299A3 (en) 2000-05-16
SK283056B6 (sk) 2003-02-04
PE61799A1 (es) 1999-09-10
DK0971882T3 (da) 2003-03-31
UA57066C2 (uk) 2003-06-16
AU741476B2 (en) 2001-11-29
EA002439B1 (ru) 2002-04-25
CA2285197A1 (en) 1998-10-08
CN1257478A (zh) 2000-06-21
NO994682D0 (no) 1999-09-24
EA199900879A1 (ru) 2000-04-24
WO1998043947A1 (en) 1998-10-08
EP0971882B1 (en) 2002-12-04
ZA982558B (en) 1999-09-27
OA11200A (en) 2003-05-21
TR199902356T2 (xx) 2000-01-21
US20040092771A1 (en) 2004-05-13
DE69809891T2 (de) 2003-07-24
KR20010005566A (ko) 2001-01-15
MA26477A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DE60115394D1 (de) Benzamide und ähnliche inhibitoren vom faktor xa
DE3263734D1 (en) Derivatives of 1-aryl-2-aminomethyl-cyclopropane-carboxamides (z), their preparation and their use as medicines in the treatment of disorders of the central nervous system
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
BG106586A (en) Pyrazolopyramidines as therapeutic agents
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
SE0104332D0 (sv) Therapeutic agents
DE69527506T2 (de) Delta 12,16-isotaxol analoge mit antineoplastischer wirkung und pharmazeutische zusammensetzungen sie enthaltend
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
GB9305295D0 (en) Therapeutic compounds
GB9310095D0 (en) Therapeutic compounds
BR9813604A (pt) Hidrato de sal de ácido maleico 5-[4-[2- (n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
AR023560A1 (es) Una forma polimorfica de acido maleico de un derivado de tiazolidin-2,4-diona, composicion farmaceutica y el uso de los mismos para la preparacion de unmedicamento
UY24937A1 (es) Forma hidratada de un derivado de 4-nitrobenzamida
NO308654B1 (no) Amid-derivater, fremgangsmÕter og mellomprodukter for fremstilling derav, deres anvendelse og farmasøytiske blandinger som inneholdende dem
IL127177A (en) ANTIPYSYCHOTIC 5-(1, 3, 4, 4a, 5, 9b-HEXAHYDRO-PYRIDO (3, 4-b) INDOL-2-YLALKYL) PYRIMIDIN-4-ONE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
HUP0002929A2 (hu) Tachikinin receptor antagonista hatású 2-acilamino-propán-aminok és az ezeket tartalmazó gyógyszerkészítmények
HU9400321D0 (en) New 2-[4-(4-azolyl-butyl)-1-piperazinyl] derivatives, process for producing them and pharmaceutical compositions containing them
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
IL106751A0 (en) Pharmaceutical compositions for the treatment of reversible obstructive airways diseases
DK0500905T3 (da) Farmaceutiske midler til brug ved behandling af AIDS
NO923467D0 (no) Farmasoeytiske midler

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20071105